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complex [1, 2]. While the roles of lysine acetylation,
serine phosphorylation, and lysine methylation of
histones in chromatin remodeling are beginning to
emerge [2–5], low levels of arginine methylation Results and discussion
of histones have only recently been documented [4, CARM1 coactivator function has previously been demon-
6–9], and its physiological role is unknown. The strated only with transiently transfected reporter genes
coactivator CARM1 methylates histone H3 at Arg17 [10, 11]. Therefore, we examined the ability of CARM1,
in cooperation with p160 coactivator GRIP1, to enhanceand Arg26 in vitro [7] and cooperates
the ability of NRs, a family of hormone-regulated tran-synergistically with p160-type coactivators (e.g.,
scriptional activators [12, 13], to activate chromosomallyGRIP1, SRC-1, ACTR) and coactivators with histone
integrated reporter genes, which have well-known differ-acetyltransferase activity (e.g., p300, CBP) to
ences in chromatin structure and transcriptional activationenhance gene activation by steroid and nuclear
requirements compared with transiently transfected re-hormone receptors (NR) in transient transfection
porter genes [14]. The cell line 1471.1 contains multipleassays [10, 11]. In the current study, CARM1
tandemly integrated copies of a chloramphenicol acetyl-cooperated with GRIP1 to enhance steroid hormone-
transferase (CAT) gene controlled by aMMTV promoter,dependent activation of stably integrated mouse
which contains enhancer elements that bind the glucocor-mammary tumor virus (MMTV) promoters, and this
ticoid receptor (GR) or androgen receptor (AR). CATcoactivator function required the methyltransferase
activity was stimulated by the glucocorticoid dexametha-activity of CARM1. Chromatin immunoprecipitation
sone (dex), which activates the endogenous GR in theseassays and immunofluorescence studies indicated
cells (Figure 1a). Coexpression of GRIP1 by transientthat CARM1 and the CARM1-methylated form of
transfection of a GRIP1 expression plasmid enhancedhistone H3 specifically associated with a large
CAT activity 2-fold, and coexpression of GRIP1 plustandem array of MMTV promoters in a hormone-
CARM1 caused a 4-fold increase. All activity was hormonedependent manner. Thus, arginine-specific histone
dependent, indicating that the activity of the coactivatorsmethylation by CARM1 is an important part of the
was entirely dependent on hormone-activated GR. Simi-transcriptional activation process.
larly, when the cells were transfected with a vector ex-
pressing AR and treated with dihydrotestosterone (DHT)
to activate AR, coexpression of CARM1 and GRIP1 to-Addresses: Departments of *Pathology and † Biochemistry and
Molecular Biology, HMR 301, University of Southern California, gether caused a synergistic 5-fold increase in CAT activity
2011 Zonal Avenue, Los Angeles, California 90089, USA. ‡ Laboratory (Figure 1b,c). A CARM1 mutant (VLD) lacking methyl-
of Receptor Biology and Gene Expression, Building 41, Room B602, transferase activity failed to enhance CAT activity in co-National Cancer Institute, Bethesda, Maryland 20892, USA.
operation with GRIP1 (Figure 1c). Thus, on a stably inte-§ Department of Biochemistry and Molecular Genetics, University of
Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA. grated reporter gene, the coactivator function of CARM1
¶ Department of Biochemistry and Molecular Biology, University of required its methyltransferase activity and the coexpres-
California, Irvine, California 92697, USA. ¥Upstate Biotechnology, 10 sion of GRIP1 (Figure 1), as shown previously for tran-
Old Barn Road, Lake Placid, New York 12946, USA.
siently transfected reporter genes [10].
To test whether histone H3 is methylated by CARM1 inCorrespondence: Michael R. Stallcup
E-mail: stallcup@usc.edu connection with promoter activation in vivo, we devel-
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Figure 1 Figure 2
Antiserum specific for CARM1-methylated histone H3. Purified calf
thymus histone H3 or H4 or unfractionated core calf thymus histones
(Hs) were incubated with S-adenosylmethionine and recombinant
GST-CARM1 or GST-PRMT1. Immunoblots were performed with
antisera as follows: (a) -methyl(R17)H3, (b) -methyl(R3)H4, (c)
against unmethylated histone H3.
specific protein methyltransferase [4]. The -meth-
yl(R17)H3 antiserum also failed to recognize three differ-
ent nonhistone proteins methylated in vitro by CARM1
and one nonhistone protein methylated by PRMT1 (data
not shown). In contrast, antiserum -methyl(R3)H4 [8]
against PRMT1-methylated histone H4 failed to recog-
nize theCARM1-methylated histoneH3 or unmethylated
histone H4, but reacted with PRMT1-methylated H4
(Figure 2b). An antibody against unmodified histone H3
was used to show that histone H3 was present in lanes
1–3 (Figure 2c). Thus, the -methyl(R17)H3 antiserum
was highly specific for CARM1-methylated histone H3.
Chromatin immunoprecipitation assays were then used
Coactivator function by CARM1 and GRIP1 with stably integrated to test whether CARM1 recruitment andCARM1-specificMMTV-CAT reporter genes. Cell line 1471.1 was transfected with
methylation of histoneH3 occurred in vivo on theMMTVexpression vectors for IL-2 receptor and the following proteins as
indicated: GRIP1, CARM1 or CARM1 VLD-to-AAA mutant, and AR. promoter during its activation by glucocorticoid hormone.
Transfected cells were grown without hormone or with (a) 100 nM Antibodies against various proteins were used to immuno-
dex (for endogenous GR) or (b,c) 100 nM DHT (for transfected precipitate cross-linked, sheared chromatin fragmentsAR), as indicated. Cells expressing IL-2 receptor were isolated from
from dex-treated or untreated 1471.1 cells; DNA fromnontransfected cells by magnetic bead sorting, and cell extracts
the immunoprecipitates was then analyzed by polymerasewere assayed for CAT activity.
chain reaction (PCR) using primers that bracket the glu-
cocorticoid response elements of the MMTV promoter.
As expected, GR and RNA polymerase II were associ-
ated with the MMTV promoter in a hormone-dependentoped antibodies that specifically recognize the CARM1-
methylated form of histone H3, using a histone H3 pep- manner (Figure 3a). Similarly, CARM1 antiserum and the
-methyl(R17)H3 antiserum precipitated the hormone-tide containing asymmetric dimethylarginine at position
17. On immunoblots, the -methyl(R17)H3 antiserum activated MMTV promoter more efficiently than the
inactive MMTV promoter, indicating that CARM1 andrecognized calf thymus histoneH3methylated byCARM1,
but not unmethylated histones H3 and H4 or histone CARM1-methylated histone H3 were more highly associ-
ated with the hormone-activated promoter (Figure 3a,b).H4 methylated by PRMT1 (Figure 2a), another arginine-
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Figure 3
Detection of CARM1 and CARM1-specific
methylation of histone H3 on the MMTV
promoter by chromatin immunoprecipitation.
(a) 1471.1 cells were incubated without or
with 100 nM dex for 40 min. Sheared
chromatin was prepared from cross-linked
cells, and chromatin immunoprecipitation
assays were conducted with antibodies
against the indicated proteins, as described
in the Materials and methods. DNA was
isolated from the immunoprecipitates, and the
presence of the nucleosome B region of the
MMTV promoter (which contains the
glucocorticoid response elements)
was detected by PCR. Before
immunoprecipitation, a fraction of the
sheared chromatin was reserved, and PCR
analysis of the isolated DNA was conducted
(input). The negative images of ethidium chromatin immunoprecipitation experiment, immunoprecipitated DNA used for PCR are
bromide-stained PCR products from a single using antibodies against CARM1 or indicated below each panel. PCR was
experiment are shown. The results shown are -methyl(R17)H3 antibodies against the performed with primers for the MMTV
typical of three independent experiments. (b) CARM1-methylated form of histone H3, are promoter (MMTV-GRE) as in (a), or primers
The results of a second, independent shown. Fractions of the total for the -actin 5-untranslated region (-actin).
In control PCR reactions with DNA from the same immu- v-RasRNA at the array. The -methyl(R17)H3 antiserum
produced a general nuclear staining, but was excludednoprecipitations with CARM1 and -methyl(R17)H3 an-
tisera, the 5-untranslated region of the -actin gene pro- from nucleoli; in addition, it stained the MMTV-Ras
arrays intensely in cells treated with dex (Figure 4a, mid-duced a very weak signal that was not affected by hormone
treatment of the cells (Figure 3b). Only specific proteins dle panels), as indicated by the intense red spot in each
nucleus at the same location as each intense green spotand histone modifications were targeted to the MMTV
promoter by the hormone: normal rabbit IgG failed to in the panel to the left. Overlay of the RNA-FISH and
-methyl(R17)H3 images confirmed that the region in-precipitate theMMTV promoter, and antibodies that spe-
cifically recognize histone H3 methylated at lysine 4 tensely stained by -methyl(R17)H3 antiserum in each
cell corresponds to the MMTV-Ras array (Figure 4a, right(-methyl(K4)H3) or lysine 9 (-methyl(K9)H3) produced
weak signals that were not affected by dex treatment (Fig- panels, intense yellow spot in each nucleus). In the ab-
sence of dex, the -methyl(R17)H3 antiserum still pro-ure 3a). Methylation of Lys9 was recently associated with
heterochromatin formation [5], while methylation of Lys4 duced the general nuclear staining (exclusive of nucleoli),
but no intensely staining regions were observed (Figurehas been suggested as a marker for transcriptionally com-
petent chromatin [2], although its specific association with 4c). Thus, the antiserum against the CARM1-methylated
histone H3 recognized the MMTV-Ras array only whenactive genes has not yet been fully explored. Thus, not
all methyl modifications on histones have the same func- the array was transcriptionally active.
tional consequences.
In control experiments, -methyl(K4)H3 antiserum pro-
duced the same type of general nuclear staining patternAs a further test of hormone-dependent, CARM1-specific
methylation of histone H3 in vivo, we used immunofluo- (excluding nucleoli) as the -methyl(R17)H3 antiserum.
However, in dex-treated cells, the -methyl(K4)H3 anti-rescence microscopy to examine the interaction in situ of
the -methyl(R17)H3 antiserum with stably integrated serum was excluded from the active MMTV-Ras array
(Figure 4b): note that there is no intense red immunofluo-MMTV promoters. In cell line 3134, approximately 200
tandemly integrated copies of an MMTV-Ras transcrip- rescence spot (middle panels) corresponding to the green
RNA-FISH spot (left panels), and that, in theRNA-FISH/tion unit (MMTV promoter driving a v-Ras gene) form a
chromatin cluster or array that can be visualized in living immunofluorescence overlay photos, the arrays are green
when the -methyl(K4)H3 antiserum was used (Figurecells by the hormone-dependent binding of GR attached
to green fluorescent protein [15]. Fluorescence in situ 4b, right panels), in contrast to the yellow overlay spot
observed with -methyl(R17)H3 antiserum (Figure 4a,hybridization against v-Ras RNA (RNA-FISH) also de-
tected nascent transcripts on the array after dex treatment right panels). Thus, in dex-treated cells, the arrays con-
tained histone H3 methylated at Arg17, but not at Lys4;(Figure 4a,b, left panels, intense green spot in each nu-
cleus), but not in the absence of dex (Figure 4c,d, left this result is consistent with our chromatin immunoprecip-
itation data (Figure 3). Interestingly and unexpectedly,panels), indicating the hormone-dependent synthesis of
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Figure 4
Immunofluorescence analysis of CARM1-specific methylation of right panels), coincident staining is shown in yellow. Antisera used
histone H3 in a transcriptionally active array of MMTV promoters. were (a,c) -methyl(R17)H3 at 1:100 dilution or (b,d)
Cell line 3134 [16] was grown (a,b) with or (c,d) without 100 nM -methyl(K4)H3 at 1:100 dilution. Confocal microscopy images were
dex for 30 min. RNA-FISH to detect v-Ras RNA [15] (green, left panels) obtained as previously described [17]. Images of single nuclei are
and immunofluorescence [17] (red, center panels) were performed as extracted from the panel immediately above.
previously described; in the merged red and green images (Overlay,
when cells were not treated with dex, the -meth- ylation of arginine residues in histone H3 may occur tran-
yl(K4)H3 antiserum, but not the-methyl(R17)H3 antise- siently in connection with transcriptional activation or on
rum, interacted with the MMTV-Ras arrays (intense red a small subset of promoters. In keeping with this idea, it
spot in middle and right panels of Figure 4d, but not has also been recently reported that the steady state levels
Figure 4c). This staining of the array by the -meth- of histone H4 methylation at Arg3 by PRMT1 in vivo are
yl(K4)H3 antiserumdisappeared after dex treatment (Fig- quite low [8, 9]. Nevertheless, when arrays of MMTV
ure 4b). The significance of the -methyl(K4)H3 staining promoters were activated by hormone, we observed a
of the array in the absence (but not in the presence) of concomitant appearance of methylated histone H3 in the
hormone is not clear but may suggest that Lys4 methyla- array (Figures 3 and 4), indicating that arginine-specific
tion of H3 marks chromatin that is competent for tran- histone methylation occurred during chromatin remodel-
scription but not yet fully activated. ing and transcriptional activation. The -methyl(R17)H3
antiserum was specific for the CARM1-methylated form
of histone H3 (Figure 2), and CARM1 is the only knownConclusions
arginine-specific histone H3 methyltransferase; this im-Previous studies [4, 7], and the fact that -methyl(R17)H3
plicates CARM1 as the enzyme responsible for the ob-antiserum fails to produce a convincingly specific signal
served histone methylation on the MMTV promoter.on immunoblots with bulk mammalian histones (Figure
This conclusion is supported by our demonstration that2 and data not shown), suggest that the overall cellular
CARM1 is recruited to the MMTV promoter in responselevel of Arg17 methylation of histone H3 is extremely
low. It therefore seems likely that CARM1-specific meth- to hormonal activation (Figure 3), that CARM1 (in collab-
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glucocorticoid receptor: rapid exchange with regulatoryoration with p160 coactivators like GRIP1) can serve as
sites in living cells. Science 2000, 287:1262-1265.
a transcriptional coactivator for GR on stably integrated 16. Kramer PR, Fragoso G, Pennie W, Htun H, Hager GL, Sinden RR:
Transcriptional state of the mouse mammary tumor virusMMTV-CAT reporter genes (Figure 1) and on transiently
promoter can affect topological domain size in vivo. J Bioltransfected reporter genes [10, 11], and that the methyl- Chem 1999, 274:28590-28597.
transferase activity of CARM1 is required for its coactiva- 17. Baumann CT, Ma H, Wolford R, Reyes JC, Maruvada P, Lim C, et
al.: The glucocorticoid receptor interacting protein 1 (GRIP1)tor function on both stable and transient reporter genes
localizes in discrete nuclear foci that associate with ND10
(Figure 1) [10]. Our findings provide the first in vivo bodies and are enriched in components of the 26S
proteasome. Mol Endocrinol 2001, 15:485-500.evidence that arginine methylation of histones, catalyzed
by recruited coactivators such as CARM1, occurs at target
promoters as an important part of the transcriptional acti-
vation process. The parallels to the paradigm already well
established for histone acetylation are obvious and suggest
that histone methylation, probably on both arginine and
lysine residues, is also part of the chromatin remodeling
process that accompanies transcriptional activation.
Supplementary material
Supplementary material including Materials and methods with addi-
tional references is available at http://images.cellpress.com/supmat/
supmatin.htm.
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